ZEAL - (Zealand Pharma A/S)

 ZEALのチャート


 ZEALの企業情報

symbol ZEAL
会社名
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種   
概要 事業概要 --     
本社所在地 --
代表者氏名
代表者役職名
電話番号
設立年月日 --
市場名 --
ipoyear 2017年
従業員数 -
url
nasdaq_url https://www.nasdaq.com/symbol/zeal
adr_tso 3583180
EBITDA EBITDA ー
終値(lastsale) 14.89
時価総額(marketcap) 53353550.2
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 ZEALのテクニカル分析


 ZEALのニュース

   Zealand Pharma to Participate in Morgan Stanley 19th Annual Global Healthcare Conference  2021/09/03 12:30:00 Finanzen AT
Company announcement – No. 57 / 2021 Zealand Pharma to Participate in Morgan Stanley 19 th Annual Global Healthcare Conference Copenhagen, DK and Boston, MA, U.S. September 3 , 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a…
   Spinal Decompression Market Industry Analysis and Forecast Till 2027|Sanofi-Aventis Llc, Zealand Pharma A/S, Kuros Biosciences  2021/08/27 11:46:38 OpenPR
The spine is gently stretched during spinal decompression. The force and position of the spine are altered as a result. By creating negative pressure in the disc, this alteration relieves pressure on the spinal discs, which are gel-like cushions between
   Employee Elected Director to step down from the board of Zealand Pharma A/S  2021/08/13 20:05:00 Intrado Digital Media
Company announcement No. 51 / 2021
   Zealand Pharma A/S (ZEAL) CEO Emmanuel Dulac on Q2 2021 Results - Earnings Call Transcript  2021/08/12 23:38:03 Seeking Alpha
   Zealand Pharma A/S 2021 Q2 - Results - Earnings Call Presentation  2021/08/12 15:21:11 Seeking Alpha
   Zealand Pharma A/S Final Transactions Under Share Repurchase Program  2021/07/27 20:05:00 Intrado Digital Media
C ompany a nnouncement No. 47 / 202 1
   Zealand Pharma A/S. - ADR Shares Near 52-Week Low - Market Mover  2021/07/15 00:05:12 Kwhen Finance
Zealand Pharma A/S. - ADR (ZEAL) shares closed today at 100.0% below its 52 week low of $27.90, giving the company a market cap of $1B. The stock is currently down 21.1% year-to-date, down 17.9% over the past 12 months, and up 59.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.7%, and the S&P 500 rose 0.4%. Trading Activity Trading volume this week was 93.6% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   ZEALAND PHARMA A/S - TRANSACTIONS UNDER SHARE REPURCHASE PROGRAM  2021/07/06 15:55:00 Intrado Digital Media
Company announcement No. 45 / 202 1
   Zeal Aqua reports standalone net loss of Rs 0.59 crore in the March 2021 quarter  2021/07/01 13:12:00 Business Standard
Sales decline 36.84% to Rs 56.62 crore
   Zealand Pharma A/S - Share Buy-Back Program Under Safe Harbour to Aquire Danish Common Stock for Employee Incentive Programs  2021/06/28 20:05:00 Intrado Digital Media
Company announcement No. 42/ 2021
   Zealand Pharma A/S Final Transactions Under Share Repurchase Program  2021/07/27 20:05:00 Intrado Digital Media
C ompany a nnouncement No. 47 / 202 1
   Zealand Pharma A/S. - ADR Shares Near 52-Week Low - Market Mover  2021/07/15 00:05:12 Kwhen Finance
Zealand Pharma A/S. - ADR (ZEAL) shares closed today at 100.0% below its 52 week low of $27.90, giving the company a market cap of $1B. The stock is currently down 21.1% year-to-date, down 17.9% over the past 12 months, and up 59.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.7%, and the S&P 500 rose 0.4%. Trading Activity Trading volume this week was 93.6% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   ZEALAND PHARMA A/S - TRANSACTIONS UNDER SHARE REPURCHASE PROGRAM  2021/07/06 15:55:00 Intrado Digital Media
Company announcement No. 45 / 202 1
   Zeal Aqua reports standalone net loss of Rs 0.59 crore in the March 2021 quarter  2021/07/01 13:12:00 Business Standard
Sales decline 36.84% to Rs 56.62 crore
   Zealand Pharma A/S - Share Buy-Back Program Under Safe Harbour to Aquire Danish Common Stock for Employee Incentive Programs  2021/06/28 20:05:00 Intrado Digital Media
Company announcement No. 42/ 2021

 関連キーワード  (― 米国株 ZEAL Zealand Pharma A/S)

 twitter  (公式ツイッターやCEOツイッターなど)